Management of bladder cancer in older patients: Position paper of a SIOG Task Force.

Abstract:

:Median age at bladder cancer (BC) diagnosis is older than for other major tumours. Age should not determine treatment, and patients should be fully involved in decisions. Patients should be screened with Mini-Cog™ for cognitive impairment and the G8 to ascertain need for comprehensive geriatric assessment. In non-muscle invasive disease, older adult patients should have standard therapy. Age does not contraindicate intravesical therapy. Independent of age and fitness, patients with muscle-invasive BC should have at least cross-sectional imaging. Data suggest extensive undertreatment in older adult patients, leading to poor outcomes. Standard treatment for a fit patient differs between countries. Radical cystectomy and trimodality therapy are first-line options. Radical cystectomy patients should be referred to an experienced centre and prehabilitation is mandatory. Older adult patients should be considered for neoadjuvant and adjuvant therapy, according to guidelines. In urinary diversion, avoiding bowel surgery for reconstruction of the lower urinary tract significantly reduces complications. If a patient is unfit for or refuses standard treatment, RT alone, or TURBT in selected cases should be considered. In metastatic BC, older adult patients should receive standard systemic therapy, depending on fitness for cisplatin and prognosis. Efficacy and tolerability of immunotherapy (IO) appears similar to younger patients. Second line IO is standard in platinum pre-treated patients, with benefit and tolerability in the older adult similar to younger patients. The toxicity profile seems to favour IO in the older adult but more data are needed. Patients progressing on IO may respond to further systemic treatment. In metastatic disease, palliative care should begin early.

journal_name

J Geriatr Oncol

authors

Mottet N,Ribal MJ,Boyle H,De Santis M,Caillet P,Choudhury A,Garg T,Nielsen M,Wüthrich P,Gust KM,Shariat SF,Gakis G

doi

10.1016/j.jgo.2020.02.001

subject

Has Abstract

pub_date

2020-09-01 00:00:00

pages

1043-1053

issue

7

eissn

1879-4068

issn

1879-4076

pii

S1879-4068(19)30481-3

journal_volume

11

pub_type

杂志文章,评审
  • Older survivors of cancer in the COVID-19 pandemic: Reflections and recommendations for future care.

    abstract:PURPOSE:Although the year after cancer treatment is challenging for all cancer survivors, older adults (≥60 years) face additional challenges due to age-related decline and high rates of comorbidity. There is a paucity of research on how health service interruptions from the COVID-19 pandemic have impacted the experien...

    journal_title:Journal of geriatric oncology

    pub_type: 杂志文章

    doi:10.1016/j.jgo.2020.11.009

    authors: Haase KR,Kain D,Merchant S,Booth C,Koven R,Brundage M,Galica J

    更新日期:2020-12-03 00:00:00

  • Implementing and validating a care protocol for older adults with cancer in resource limited settings with a newly developed screening tool.

    abstract:BACKGROUND:Cancer in the aging population presents manifold challenges. In the resource-limited settings of developing countries, concrete steps to optimize care for older adults with cancer are required. MATERIALS AND METHOD:This prospective, observational study was divided in two parts. In the first part, older adul...

    journal_title:Journal of geriatric oncology

    pub_type: 杂志文章

    doi:10.1016/j.jgo.2020.04.013

    authors: Banerjee J,Behal P,Satapathy S,Kandel R,Upadhyay AD,Dwivedi S,Kumar L,Dey AB

    更新日期:2021-01-01 00:00:00

  • Potential drug-drug interactions and risk of unplanned hospitalization in older patients with cancer: A survey of the prospective ELCAPA (ELderly CAncer PAtients) cohort.

    abstract:BACKGROUND:Because of comorbidities and polypharmacy, older patients with cancer have a greater risk of iatrogenic events. We aimed to characterize potential drug-drug interactions (PDIs) and the risk of unplanned hospitalization in older patients with cancer treated with antineoplastic agents (ANAs). METHODS:We analy...

    journal_title:Journal of geriatric oncology

    pub_type: 杂志文章

    doi:10.1016/j.jgo.2019.07.023

    authors: Beinse G,Reitter D,Segaux L,Carvahlo-Verlinde M,Rousseau B,Tournigand C,Cudennec T,Laurent M,Boudou-Rouquette P,Paillaud E,Canouï-Poitrine F,Caillet P,ELCAPA Study Group.

    更新日期:2020-05-01 00:00:00

  • Patient-reported psychosocial needs and psychological distress predict survival in geriatric oncology patients.

    abstract:OBJECTIVES:Little is known about how psychosocial factors and distress affect older patients with cancer and their survival. The study goals were to: 1) observe the prevalence of anxiety (ANX) and depression (DEP) symptoms at diagnosis in patients aged ≥65 years, 2) observe the association between social isolation (iso...

    journal_title:Journal of geriatric oncology

    pub_type: 杂志文章

    doi:10.1016/j.jgo.2020.10.001

    authors: Leung B,Shokoohi A,Bates A,Ho C

    更新日期:2020-11-04 00:00:00

  • Management and supportive treatment of frail patients with metastatic pancreatic cancer.

    abstract::Data regarding management of frail patients with pancreatic ductal adenocarcinoma practice is currently very scarce. Randomized clinical trials usually exclude these subgroup of patients and the majority of the publications only consider chronological age and ECOG performance status for their classification. Therefore...

    journal_title:Journal of geriatric oncology

    pub_type: 杂志文章,评审

    doi:10.1016/j.jgo.2018.06.005

    authors: Macarulla T,Carrato A,Díaz R,García A,Laquente B,Sastre J,Álvarez R,Muñoz A,Hidalgo M

    更新日期:2019-05-01 00:00:00

  • Sociodemographic, socioeconomic, and clinical determinants of survival in patients with cancer: A systematic review of the literature focused on the elderly.

    abstract::Studies on cancer survival have revealed disparities not only between the elderly and their younger counterparts, but also among the elderly themselves. The aim of this work was to identify sociodemographic, socioeconomic, clinical, and care-related determinants of survival or mortality in older patients with cancer b...

    journal_title:Journal of geriatric oncology

    pub_type: 杂志文章

    doi:10.1016/j.jgo.2017.07.007

    authors: Galvin A,Delva F,Helmer C,Rainfray M,Bellera C,Rondeau V,Soubeyran P,Coureau G,Mathoulin-Pélissier S

    更新日期:2018-01-01 00:00:00

  • The prevalence of luminal B subtype is higher in older postmenopausal women with ER+/HER2- breast cancer and is associated with inferior outcomes.

    abstract:OBJECTIVES:To establish whether clinicopathologic and genomic characteristics may explain the poor prognosis associated with advanced age in ER+/HER2- breast cancer. MATERIALS AND METHODS:The cohort included 271 consecutive post-menopausal patients with ER+/HER2- invasive breast cancer ages 55 years and older. Patient...

    journal_title:Journal of geriatric oncology

    pub_type: 杂志文章

    doi:10.1016/j.jgo.2020.08.007

    authors: Mills M,Liveringhouse C,Lee F,Nanda RH,Ahmed KA,Washington IR,Thapa R,Fridley BL,Blumencranz P,Extermann M,Loftus L,Balducci L,Diaz R

    更新日期:2020-08-25 00:00:00

  • Impact of age on treatment trends and clinical outcome in patients with metastatic renal cell carcinoma.

    abstract:OBJECTIVES:Clinical outcomes in older adults with metastatic renal cell carcinoma (mRCC) are poorly understood, particularly in the era of targeted therapies. We characterize survival and relevant treatment-related variables in a modern series. MATERIALS AND METHODS:From an institutional database including 562 patient...

    journal_title:Journal of geriatric oncology

    pub_type: 杂志文章

    doi:10.1016/j.jgo.2012.11.001

    authors: Pal SK,Hsu J,Hsu S,Hu J,Bergerot P,Carmichael C,Saikia J,Liu X,Lau C,Twardowski P,Figlin RA,Yuh BF

    更新日期:2013-04-01 00:00:00

  • Similar survival rates with first-line gefitinib, gemcitabine, or docetaxel in a randomized phase II trial in elderly patients with advanced non-small cell lung cancer and a poor performance status (IFCT-0301).

    abstract:OBJECTIVES:We evaluated the impact of age in a randomized phase II trial that compared three first-line drugs in elderly patients with advanced non-small cell lung cancer (NSCLC) and a poor performance status (PS). MATERIALS AND METHODS:Patients with advanced NSCLC with a PS of 2 or 3 were enrolled into a multicenter ...

    journal_title:Journal of geriatric oncology

    pub_type: 杂志文章,多中心研究,随机对照试验

    doi:10.1016/j.jgo.2015.02.002

    authors: Des Guetz G,Landre T,Westeel V,Milleron B,Vaylet F,Urban T,Barlesi F,Souquet PJ,Debieuvre D,Braun D,Fraboulet G,Monnet I,Uzzan B,Molinier O,Morin F,Moro-Sibilot D,Morère JF

    更新日期:2015-05-01 00:00:00

  • Detection of frailty in elderly cancer patients: Improvement of the G8 screening test.

    abstract:OBJECTIVE:The G8 is a screening test to identify frail elderly patients with cancer. Objectives were to design and evaluate the performance of alternative tests taking into account other predictive domains for frailty. METHODS:We conducted a literature review to identify predictive factors of frailty. Using a Delphi c...

    journal_title:Journal of geriatric oncology

    pub_type: 杂志文章

    doi:10.1016/j.jgo.2016.01.004

    authors: Petit-Monéger A,Rainfray M,Soubeyran P,Bellera CA,Mathoulin-Pélissier S

    更新日期:2016-03-01 00:00:00

  • Benefits of minimally-invasive surgery for sigmoid and rectal cancer in older adults compared with younger adults: Do older adults have the most to gain?

    abstract:INTRODUCTION:Randomized trials demonstrated oncologic safety and short-term benefits of laparoscopy. We investigated if the benefit of laparoscopy on short-term outcomes is greater for older adults compared with younger adults. METHODS:We identified all older (≥70 years old) and younger (<70) adults with primary sigmo...

    journal_title:Journal of geriatric oncology

    pub_type: 杂志文章

    doi:10.1016/j.jgo.2019.09.018

    authors: Chesney TR,Quereshy HA,Draginov A,Chadi SA,Quereshy FA

    更新日期:2020-06-01 00:00:00

  • Aromatase inhibitors: The unexpected breast cancer treatment.

    abstract:OBJECTIVE:Suboptimal adherence with endocrine treatment for breast cancer is influenced by a number of factors but remains poorly understood. We sought to describe the prior knowledge about and expectations of breast cancer treatments among older women retrospecting on their diagnosis and treatment. METHODS:Thematic a...

    journal_title:Journal of geriatric oncology

    pub_type: 杂志文章

    doi:10.1016/j.jgo.2019.07.024

    authors: Pieters HC,Green E,Sleven M,Stanton AL

    更新日期:2020-04-01 00:00:00

  • Decision-making and cancer screening: a qualitative study of older adults with multiple chronic conditions.

    abstract:OBJECTIVE:To understand how older persons with multiple chronic conditions (MCC) approach decisions about cancer screening. MATERIALS AND METHODS:We conducted interviews with adults >65 years old with at least two chronic conditions who were taking ≥five medications daily. Patients were first asked how age and multimo...

    journal_title:Journal of geriatric oncology

    pub_type: 杂志文章

    doi:10.1016/j.jgo.2014.12.001

    authors: Gross CP,Fried TR,Tinetti ME,Ross JS,Genao I,Hossain S,Wolf E,Lewis CL

    更新日期:2015-03-01 00:00:00

  • Impact of a pharmacist and geriatrician medication review on drug-related problems in older outpatients with cancer.

    abstract:OBJECTIVES:Older patients with cancer have increased risk for comorbidity, polypharmacy (PP) and drug related problems (DRP). The aim of this study was to assess the effect of a clinical pharmacist and geriatrician medication review (MR) among older outpatients with cancer to optimize management of comorbidities during...

    journal_title:Journal of geriatric oncology

    pub_type: 杂志文章

    doi:10.1016/j.jgo.2020.07.010

    authors: Choukroun C,Leguelinel-Blache G,Roux-Marson C,Jamet C,Martin-Allier A,Kinowski JM,Le Guillou C,Richard H,Antoine V

    更新日期:2021-01-01 00:00:00

  • The relevance of geriatric assessment for older patients receiving palliative chemotherapy.

    abstract:OBJECTIVES:No tools accurately discriminate between older patients who are fit and those who are frail to tolerate systemic palliative treatment. This study evaluates whether domains of geriatric assessment (GA) are associated with increased risk of chemotherapy intolerance in patients who were considered fit to start ...

    journal_title:Journal of geriatric oncology

    pub_type: 杂志文章

    doi:10.1016/j.jgo.2019.05.016

    authors: van der Vlies E,Kurk SA,Roodhart JML,Gerritse FL,Pelgrim TC,Vos JM,Sohne M,Hunting CB,Noordzij PG,van der Velden AMT,Los M

    更新日期:2020-04-01 00:00:00

  • Effect of advanced age on peri-operative outcomes after robotic-assisted pulmonary lobectomy: Retrospective analysis of 287 consecutive cases.

    abstract:OBJECTIVES:We investigated whether advanced age affects peri-operative outcomes after robotic-assisted pulmonary lobectomies. MATERIALS AND METHODS:We retrospectively analyzed patients who underwent robotic-assisted lobectomy by one surgeon over a 5-year period. Rates of postoperative complications were compared accor...

    journal_title:Journal of geriatric oncology

    pub_type: 杂志文章

    doi:10.1016/j.jgo.2016.11.003

    authors: Kass KS,Velez-Cubian FO,Zhang WW,Toosi K,Tanvetyanon T,Rodriguez KL,Thau MR,Garrett JR,Moodie CC,Fontaine JP,Toloza EM

    更新日期:2017-03-01 00:00:00

  • Envisioning Arti's 'Cadillac study' to assess aging trajectories in cancer survivors.

    abstract::The "Cadillac Study" was the term Arti Hurria, MD often used to articulate her vision of the optimal study to investigate the effects of cancer and its treatments on aging trajectories. In her opinion, this study needed to be designed for near-term clinical translation and have the ability to discern subpopulations of...

    journal_title:Journal of geriatric oncology

    pub_type: 杂志文章

    doi:10.1016/j.jgo.2019.06.009

    authors: Guida JL,Green PA,Gallicchio L

    更新日期:2020-03-01 00:00:00

  • Impact of geriatric assessment on the management of older adults with head and neck cancer: A pilot study.

    abstract:OBJECTIVE:Assess the utility of the G8 screening tool and CGA for older adults with head and neck cancer. METHODS:Patients 65years or older with a primary malignancy of the head and neck region were presented at the multidisciplinary team (MDT) meeting. The Geriatric 8 (G8) questionnaire was administered prior. Clinic...

    journal_title:Journal of geriatric oncology

    pub_type: 临床试验,杂志文章

    doi:10.1016/j.jgo.2016.05.006

    authors: Neve M,Jameson MB,Govender S,Hartopeanu C

    更新日期:2016-11-01 00:00:00

  • Controversial issues in the management of older adults with early breast cancer.

    abstract::It is well recognized that the incidence of breast cancer increases significantly with age. Despite this, older people remain under-represented in many clinical trials and their management relies on extrapolation of data from younger patients. Providing an aggressive intervention can be challenging, particularly in le...

    journal_title:Journal of geriatric oncology

    pub_type: 杂志文章,评审

    doi:10.1016/j.jgo.2017.05.004

    authors: Mislang AR,Cheung KL,Hamaker ME,Kunkler I,Markopoulos C,Orecchia R,Brain E,Biganzoli L

    更新日期:2017-11-01 00:00:00

  • Management of primary metastatic breast cancer in elderly patients--an international comparison of oncogeriatric versus standard care.

    abstract:BACKGROUND:An oncogeriatric approach may affect management of elderly patients with breast cancer. However, little is known about oncogeriatric care in the metastatic setting. Therefore, we performed an international comparison of management of elderly patients with primary metastatic disease who were treated in two di...

    journal_title:Journal of geriatric oncology

    pub_type: 杂志文章,多中心研究

    doi:10.1016/j.jgo.2014.02.005

    authors: van de Water W,Bastiaannet E,Egan KM,de Craen AJ,Westendorp RG,Balducci L,van de Velde CJ,Liefers GJ,Extermann M

    更新日期:2014-07-01 00:00:00

  • Is Age ≥ 70 Years an Important Predictor of Adverse Events Among Patients Enrolled in Metastatic Melanoma Trials? Findings from Pooled Analyses of Therapeutic Trials.

    abstract::BACKGROUND: The current study was undertaken to explore whether older age predicts adverse event rates in metastatic melanoma patients participating in cancer clinical trials. METHODS: Six phase II studies conducted at our institution for patients with metastatic disease were used in these pooled analyses: 1) ABT-510...

    journal_title:Journal of geriatric oncology

    pub_type: 杂志文章

    doi:10.1016/j.jgo.2012.04.002

    authors: Jatoi A,Allred JB,Suman VJ,Creagan ET,Croghan GA,Amatruda T,Markovic SN

    更新日期:2012-10-01 00:00:00

  • Outcomes based on age in patients with metastatic renal cell carcinoma treated with first line targeted therapy or checkpoint immunotherapy: Older patients more prone to toxicity.

    abstract:OBJECTIVES:Older patients with metastatic renal cell carcinoma (mRCC) were underrepresented in pivotal trials. MATERIALS AND METHODS:Consecutive patients with mRCC treated at Aarhus University Hospital with first line tyrosine kinase inhibitors (TKI), mTOR inhibitors, or checkpoint immunotherapy (CPI) were retrospecti...

    journal_title:Journal of geriatric oncology

    pub_type: 杂志文章

    doi:10.1016/j.jgo.2020.12.008

    authors: Hermansen CK,Donskov F

    更新日期:2020-12-31 00:00:00

  • Inflammatory biomarkers, geriatric assessment, and treatment outcomes in acute myeloid leukemia.

    abstract:OBJECTIVES:To investigate changes in inflammatory biomarkers during induction therapy for older adults with acute myeloid leukemia (AML) and their associations with geriatric assessment (GA) measures and outcomes. METHODS:This was a single institution ancillary study to a prospective observational study (N = 20 consec...

    journal_title:Journal of geriatric oncology

    pub_type: 杂志文章

    doi:10.1016/j.jgo.2019.03.014

    authors: Loh KP,Tooze JA,Nicklas BJ,Kritchevsky SB,Williamson JD,Ellis LR,Powell BL,Pardee TS,Goyal NG,Klepin HD

    更新日期:2020-04-01 00:00:00

  • Optimal management of localized rectal cancer in older patients.

    abstract::In advising the optimal management for older patients, health care professionals try to balance the risks from frailty, vulnerability, and comorbidity against the patient's ultimate prognosis, potential functional outcomes and quality of life (QOL). At the same time it is important to involve the patient and incorpora...

    journal_title:Journal of geriatric oncology

    pub_type: 杂志文章,评审

    doi:10.1016/j.jgo.2018.08.001

    authors: Bujko K,Glynne-Jones R,Papamichael D,Rutten HJT

    更新日期:2018-11-01 00:00:00

  • Survival benefit of statins in older patients with rectal cancer: A Swedish population-based cohort study.

    abstract:OBJECTIVES:Increasing evidence suggests that statins may have antitumor effects but their role in rectal cancer appears inconclusive. The aim of this study was to investigate whether statins may have an impact on survival of older and younger patients with rectal cancer. MATERIALS AND METHODS:This study included 238 p...

    journal_title:Journal of geriatric oncology

    pub_type: 杂志文章

    doi:10.1016/j.jgo.2019.01.011

    authors: Kotti A,Holmqvist A,Albertsson M,Sun XF

    更新日期:2019-09-01 00:00:00

  • Single-arm phase II trial to evaluate efficacy and tolerance of regorafenib monotherapy in patients over 70 with previously treated metastatic colorectal adenocarcinoma FFCD 1404 - REGOLD.

    abstract:BACKGROUND:Regorafenib significantly increases overall survival (OS) in patients with metastatic colorectal cancer previously treated but gives toxicities. OBJECTIVES:to assess the efficacy and safety of regorafenib at it's approved dose in the older population. PATIENTS AND METHODS:This multicenter single-arm phase ...

    journal_title:Journal of geriatric oncology

    pub_type: 杂志文章

    doi:10.1016/j.jgo.2020.04.001

    authors: Aparicio T,Darut-Jouve A,Khemissa Akouz F,Montérymard C,Artru P,Cany L,Romano O,Valenza B,Le Foll C,Delbaldo C,Falandry C,Norguet Monnereau E,Ben Abdelghani M,Smith D,Rinaldi Y,Père Verge D,Baize N,Maillard E,Dohan A

    更新日期:2020-11-01 00:00:00

  • Patient-reported and objectively measured physical function in older breast cancer survivors and cancer-free controls.

    abstract:OBJECTIVES:Older breast cancer survivors (BCS) consistently report more functional limitations than women without cancer, but whether or not these differences remain when using objective measures of physical functioning and the correlates of these measures is unknown. METHODS:Cross-sectional study comparing older (≥60...

    journal_title:Journal of geriatric oncology

    pub_type: 杂志文章

    doi:10.1016/j.jgo.2018.10.006

    authors: Winters-Stone KM,Medysky ME,Savin MA

    更新日期:2019-03-01 00:00:00

  • Integrating geriatric assessment in the first line chemotherapy treatment in older patients with metastatic colorectal cancer: Results of a prospective observational cohort study (AVAPLUS).

    abstract:OBJECTIVES:This study aims to investigate the use of chemotherapy with or without bevacizumab in older patients with metastatic colorectal cancer (mCRC) in current daily practice and to identify predictive parameters for treatment-related outcomes. PATIENTS AND METHODS:This is a Belgian multi-centre, observational coh...

    journal_title:Journal of geriatric oncology

    pub_type: 杂志文章,多中心研究

    doi:10.1016/j.jgo.2017.10.002

    authors: Decoster L,Kenis C,Naessens B,Houbier G,De Man M,Lambrecht G,Monsaert E,Moons V,Vergauwe P,Prenen H,Van Cutsem E,Wildiers H

    更新日期:2018-03-01 00:00:00

  • Delirium incidence, risk factors, and treatments in older adults receiving chemotherapy: A systematic review and meta-analysis.

    abstract:INTRODUCTION:Older adults with cancer are at increased risk of delirium due to age, comorbidities, medications, cognitive impairment, and possibly cancer treatments. However, there is scant information on the risks of delirium with chemotherapy and approaches to prevent or treat it. We performed a systematic review and...

    journal_title:Journal of geriatric oncology

    pub_type: 杂志文章

    doi:10.1016/j.jgo.2020.08.011

    authors: Jung P,Puts M,Frankel N,Syed AT,Alam Z,Yeung L,Malik U,Rosario C,Ayala AP,Hudson J,Alibhai SMH

    更新日期:2020-09-14 00:00:00

  • Treatment strategies and survival outcomes in older women with breast cancer: A comparative study between the FOCUS cohort and Nottingham cohort.

    abstract:OBJECTIVE:Clinical trials investigating breast cancer treatment often exclude or misrepresent older adults. This study compares treatment patterns and survival of older women diagnosed with breast cancer between a Dutch and a British observational cohort. MATERIALS AND METHODS:Women aged 70 years and older diagnosed w...

    journal_title:Journal of geriatric oncology

    pub_type: 杂志文章

    doi:10.1016/j.jgo.2018.05.004

    authors: Schuil H,Derks M,Liefers GJ,Portielje J,van de Velde C,Syed B,Green A,Ellis I,Cheung KL,Bastiaannet E

    更新日期:2018-11-01 00:00:00